We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.61%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22B
AUM Growth
-$123M
(-0.55%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
11.79%
Holding
1,359
New
101
Increased
421
Reduced
517
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$62M |
| 2 |
UBS Group
UBS
|
+$49.7M |
| 3 |
Air Products & Chemicals
APD
|
+$47.3M |
| 4 |
AT&T
T
|
+$44.6M |
| 5 |
Lam Research
LRCX
|
+$39.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hewlett Packard
HPE
|
+$61.6M |
| 2 |
HCA Healthcare
HCA
|
+$50.8M |
| 3 |
Gen Digital
GEN
|
+$50.7M |
| 4 |
Baxter International
BAX
|
+$50.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$49.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 16.86% |
| 3 | Financials | 11.57% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Alnylam Pharmaceuticals
ALNY
$31.9B
| $11.3M | 0.05% |
141,210
-103,073
| -42% | -$6.59M |
|
|
TFCFA
377
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $11.3M | 0.05% |
397,312
+35,959
| +10% | +$1.03M |
|
|
HRC
378
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $11.2M | 0.05% |
140,800
| – | – |
|
|
DFS
379
DELISTED
Discover Financial Services
DFS
| $11.2M | 0.05% |
180,200
-254,491
| -59% | -$15.8M |
|
380
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.2B
| $11.1M | 0.05% |
97,480
-15,540
| -14% | -$1.78M |
|
381
Carnival Corporation Ltd
CCL
$30.3B
| $11.1M | 0.05% |
169,766
+5,355
| +3% | +$334K |
|
382
Jabil
JBL
$31B
| $11.1M | 0.05% |
380,600
+219,400
| +136% | +$6.45M |
|
383
AGCO
AGCO
$8.67B
| $11M | 0.05% |
163,936
+90,200
| +122% | +$5.76M |
|
|
NBL
384
DELISTED
Noble Energy, Inc.
NBL
| $11M | 0.05% |
390,157
-7,238
| -2% | -$225K |
|
|
AABA
385
DELISTED
Altaba Inc
AABA
| $11M | 0.05% |
+202,008
| New | +$11M |
|
386
iShares MSCI Japan ETF
EWJ
$23.3B
| $11M | 0.05% |
204,770
| – | – |
|
|
AERI
387
DELISTED
Aerie Pharmaceuticals
AERI
| $11M | 0.05% |
+208,580
| New | +$9.71M |
|
388
Range Resources
RRC
$9.79B
| $10.9M | 0.05% |
471,917
+97,548
| +26% | +$2.46M |
|
389
Warner Bros
WBD
$70.3B
| $10.9M | 0.05% |
422,550
+202,200
| +92% | +$5.47M |
|
390
Global Payments
GPN
$23.5B
| $10.8M | 0.05% |
119,061
-75,475
| -39% | -$6.53M |
|
|
ICPT
391
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $10.7M | 0.05% |
88,669
-3,301
| -4% | -$382K |
|
392
Aon
AON
$64.6B
| $10.7M | 0.05% |
80,404
-5,436
| -6% | -$687K |
|
|
CBPO
393
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $10.7M | 0.05% |
94,334
+14,068
| +18% | +$1.57M |
|
394
Capital One
COF
$127B
| $10.6M | 0.05% |
128,589
-19,578
| -13% | -$1.59M |
|
395
Urban Edge Properties
UE
$2.55B
| $10.5M | 0.05% |
443,808
+34,173
| +8% | +$859K |
|
396
Skyworks Solutions
SWKS
$13.5B
| $10.5M | 0.05% |
109,558
+4,900
| +5% | +$503K |
|
|
VMW
397
DELISTED
VMware, Inc
VMW
| $10.5M | 0.05% |
120,100
+60,900
| +103% | +$5.62M |
|
|
ESRX
398
DELISTED
Express Scripts Holding Company
ESRX
| $10.5M | 0.05% |
164,319
+40,300
| +32% | +$2.53M |
|
|
PARA
399
DELISTED
Paramount Global Class B
PARA
| $10.5M | 0.05% |
163,895
-75,905
| -32% | -$4.86M |
|
400
Norfolk Southern
NSC
$71.9B
| $10.3M | 0.05% |
85,013
-12,457
| -13% | -$1.46M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2017 Portfolio in Review
As of Q2 2017, Axa held 1,359 positions worth $22B, down 0.55% from $22.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Axa withdrew a net $1.19B in Q2 2017, closing 125 positions and reducing 517 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $22.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Element Solutions worth $22.3M.
- Axa's largest Q2 2017 buy was Element Solutions: 1,758,931 shares worth $22.3M.
- Axa added most to Micron Technology in Q2 2017, an estimated $62M increase.
- Axa's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $61.6M.
- Axa fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $22.7M.
- Axa's ten largest holdings make up 12% of its $22B portfolio in Q2 2017.
- Axa opened 101 new positions and closed 125 in Q2 2017.
- Axa's portfolio value fell 0.55% quarter-over-quarter to $22B.
Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.